Sarepta Therapeutics
SRPT
#5051
Rank
โ‚ฌ1.52 B
Marketcap
14,48ย โ‚ฌ
Share price
-0.94%
Change (1 day)
-56.56%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) Fails to deliver data

Key failure to deliver metrics for Sarepta Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Sarepta Therapeutics (SRPT) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Sarepta Therapeutics (SRPT) - since 2013

Volume in USD (price x number of shares), data since 2013

Sarepta Therapeutics (SRPT) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026โ‚ฌ10.45 M-49.12%
2025โ‚ฌ20.54 M-51.05%
2024โ‚ฌ41.97 M24.73%
2023โ‚ฌ33.65 M66.59%
2022โ‚ฌ20.2 M-64.04%
2021โ‚ฌ56.17 M-40.62%
2020โ‚ฌ94.6 M-66.33%
2019โ‚ฌ0.28 B16.72%
2018โ‚ฌ0.24 B253.79%
2017โ‚ฌ68.05 M-40.35%
2016โ‚ฌ0.11 B190.97%
2015โ‚ฌ39.21 M-69.48%
2014โ‚ฌ0.12 B79.12%
2013โ‚ฌ71.71 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Gilead Sciences
GILD
โ‚ฌ33.01 Mโ‚ฌ0.11 B๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
โ‚ฌ8.31 Mโ‚ฌ21.57 M๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚ฌ5.09 Mโ‚ฌ61.25 M๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ7.5 Mโ‚ฌ39.57 M๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
โ‚ฌ23.19 Mโ‚ฌ63.32 M๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚ฌ4.51 Mโ‚ฌ8.84 M๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
โ‚ฌ0.9 Mโ‚ฌ45.5 M๐Ÿ‡บ๐Ÿ‡ธ USA